Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review
Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are characterized by skin photosensitivity caused by accumulation of protoporphyrin IX. We aimed to review the clinical evidence of efficacy and safety of skin photosensitivity treatments in individuals with EPP or XLP. We systema...
Main Authors: | Ida M. Heerfordt, Catharina M. Lerche, Peter A. Philipsen, Hans Christian Wulf |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222015219 |
Similar Items
-
A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
by: Manisha Balwani, et al.
Published: (2022-12-01) -
Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria
by: Katelyn E. Madigan, et al.
Published: (2023-12-01) -
Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
by: Elena Di Pierro, et al.
Published: (2022-01-01) -
Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
by: Antoine Poli, et al.
Published: (2023-12-01) -
When the diagnosis is written in the DNA: a case of erythropoietic protoporphyria in a patient with a chromosome 18 deletion
by: Sara Rovaris, et al.
Published: (2023-09-01)